Biogen, Inc. (BIIB)
250.69
-3.15
(-1.24%)
USD |
NASDAQ |
Oct 23, 16:00
247.18
-3.51
(-1.40%)
After-Hours: 20:00
Biogen Market Cap : 37.03B for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 37.03B |
| October 22, 2026 | 37.49B |
| October 21, 2026 | 35.59B |
| October 20, 2026 | 35.91B |
| October 19, 2026 | 34.48B |
| October 16, 2026 | 34.36B |
| October 15, 2026 | 34.76B |
| October 14, 2026 | 34.39B |
| October 13, 2026 | 33.81B |
| October 12, 2026 | 33.88B |
| October 09, 2026 | 33.34B |
| October 08, 2026 | 32.26B |
| October 07, 2026 | 32.81B |
| October 06, 2026 | 32.92B |
| October 05, 2026 | 33.02B |
| October 02, 2026 | 32.48B |
| October 01, 2026 | 32.91B |
| September 30, 2026 | 33.36B |
| September 29, 2026 | 33.54B |
| September 28, 2026 | 33.78B |
| September 25, 2026 | 33.62B |
| September 24, 2026 | 33.43B |
| September 23, 2026 | 33.61B |
| September 22, 2026 | 33.29B |
| September 21, 2026 | 32.36B |
| Date | Value |
|---|---|
| September 18, 2026 | 31.83B |
| September 17, 2026 | 32.35B |
| September 16, 2026 | 31.90B |
| September 15, 2026 | 31.93B |
| September 14, 2026 | 32.10B |
| September 11, 2026 | 32.07B |
| September 10, 2026 | 31.82B |
| September 09, 2026 | 31.12B |
| September 08, 2026 | 31.39B |
| September 04, 2026 | 32.62B |
| September 03, 2026 | 33.16B |
| September 02, 2026 | 32.89B |
| September 01, 2026 | 31.91B |
| August 31, 2026 | 32.00B |
| August 28, 2026 | 32.27B |
| August 27, 2026 | 32.72B |
| August 26, 2026 | 32.65B |
| August 25, 2026 | 32.61B |
| August 24, 2026 | 32.22B |
| August 21, 2026 | 32.02B |
| August 20, 2026 | 31.66B |
| August 19, 2026 | 32.72B |
| August 18, 2026 | 31.39B |
| August 17, 2026 | 30.89B |
| August 14, 2026 | 30.99B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 504.75B |
| Gilead Sciences, Inc. | 193.65B |
| Amgen, Inc. | 237.46B |
| Ionis Pharmaceuticals, Inc. | 7.111B |
| Regeneron Pharmaceuticals, Inc. | 83.24B |
Market Cap Related Metrics
| PE Ratio | 44.40 |
| PS Ratio | 3.833 |
| Price to Book Value | 1.964 |
| Price to Free Cash Flow | 14.87 |
| Price | 250.69 |
| Earnings Yield | 2.25% |
| Operating PE Ratio | 19.66 |
| Normalized PE Ratio | 27.44 |